In the murine hematopoietic stem cell (HSC) compartment, thrombopoietin (THPO)/MPL (THPO receptor) signaling plays an important role in the maintenance of adult quiescent HSCs. However, the role of THPO/ MPL signaling in the human primitive HSC compartment has not yet been elucidated. We have identified very primitive human cord blood (CB)-derived CD34 − severe combined immunodeficiency (SCID)-repopulating cells (SRCs) using the intra-bone marrow injection method. In this study, we investigated the roles of the MPL expression in the human primitive HSC compartment. The SRC activities of the highly purified CB-derived 18Lin − CD34 +/− MPL +/− cells were analyzed using NOG mice. In the primary recipient mice, nearly all mice that received CD34 
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INTRODUCTION
In the murine primitive hematopoietic stem cell (HSC) compartment, thrombopoietin (THPO)/myeloproliferative leukemia virus (MPL) (THPO receptor) signaling plays an important role in the maintenance of adult quiescent HSCs in the osteoblastic niche 1 and in the posttransplantation HSC expansion − SRCs appear to be a counterpart of murine CD34 lo/− KSL cells. A series of our previous studies demonstrated that these human CB-derived CD34 − SRCs appear to be very primitive LT-repopulating HSCs, which reside at the apex of the human HSC hierarchy [4] [5] [6] [7] [8] [9] [10] [11] . As we reported previously, the immunophenotype of human CB-derived CD34 − SRCs is Lin Our data were consistent with reported studies showing that human bone marrow (BM)-or CB-derived LTrepopulating HSCs were c-kit low or c-kit <low cells 12, 13 . Collectively, the c-kit expression pattern appears to differ between mouse and human HSCs.
From another perspective, Kiel et al. reported that the primitiveness of hematopoietic stem/progenitor cells (HSPCs) could be predicted according to the expression patterns of the signaling lymphocyte activation molecule (SLAM) family members, including CD150, CD244, and CD48
14 . Additionally, LT-repopulating HSCs were highly purified as CD150 
MPL
− SRCs (HSCs) reside at the apex of the human HSC hierarchy. In addition, these findings suggest that the functional significance of the MPL expression in the human primitive HSC compartment may differ from that in murine primitive HSC compartment.
MATERIALS AND METHODS

CB Samples
CB samples from normal full-term deliveries were obtained with informed consent and approved by the institutional review board (IRB) of Kansai Medical University. In a separate experiment, the 18Lin − cells were stained with a mixture of mAbs plus anti-Flt3 mAb (BioLegend). Then the expression pattern of Flt3 on 18Lin − CD34 +/− MPL +/− cells was analyzed using a FACSCantoII (BD Biosciences).
Isolation of CB-
Clonal Cell Culture
Human colony-forming cells (CFCs), including megakaryocyte-containing CFCs, were assayed using our standard methylcellulose cultures, as previously reported 4, 6, [9] [10] [11] 19 . Briefly, sorted 18Lin −5 mol/L mercaptoethanol (SigmaAldrich), and six cytokines [THPO, stem cell factor (SCF; R&D Systems, Minneapolis, MN, USA), interleukin-3 (IL-3), granulocyte macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF), and erythropoietin (Epo)]. THPO, IL-3, G-CSF, GM-CSF, and Epo were provided by Kyowa Hakko Kirin Company (Tokyo, Japan). For megakaryocyte colony formation, 10% platelet-poor plasma (PPP) was added instead of 30% FCS to the methylcellulose cultures in the presence of three cytokines (THPO, IL-3, and Epo). Dishes were incubated at 37°C in a fully humidified atmosphere flushed with a combination of 5% CO 2 , 5% O 2 , and 90% N 2 . On day 10 or 14 of cultures, all colonies were scored under an inverted microscope according to their typical morphologic appearance as previously reported 4, 6, [9] [10] [11] 19 . Colony types identified in situ were CFU-GM (colonyforming unit granulocyte macrophage), BFU-E (burstforming unit erythroid), CFU-Meg (megakaryocyte), CFU-Mix (erythrocyte-containing mixed), and CFU-EM (erythrocyte/megakaryocyte mixed).
In Vitro Lineage Differentiation Assay
Eighteen Lin + fractionderived mesenchymal stromal cells (DP-MSCs) as previously reported 17 . A total of 1,000 cells were plated into each well of a 24-well culture plate (Corning Inc.). The cells were cultured in StemPro-34 serum-free medium (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with a cocktail of cytokines [100 ng/ml THPO, 50 ng/ml SCF, 50 ng/ml Flt-3 ligand (FL), 10 ng/ml G-CSF, 10 ng/ml IL-3, and 10 ng/ml IL-6]. After 7 days of coculture, the cells were collected by vigorous pipetting. The numbers of collected cells were counted, and then the cells were stained with mAbs including lineage markers (CD11b, CD14, CD33, and CD41), CD34, and CD45. The percentages of lineage marker-positive and CD34 + cells in CD45 + cells were analyzed by flow cytometry (FCM; FACSCantoII; BD Biosciences).
Mice
Female six-week-old NOD/Shi-scid/IL-2Rg c null (NOG) mice 20 were purchased from the Central Institute of Experimental Animals (Kawasaki, Japan). The mice were maintained and handled under specific pathogen-free conditions. All animal experiments were approved by the Animal Care Committees of Kansai Medical University.
SRC Assay Isolated 18Lin
− CD34 +/− MPL +/− cells were injected into the left tibiae of sublethally irradiated (250 cGy) NOG mice using an IBMI technique 4 . The numbers of transplanted cells are described in Table 2 . At weeks 5, 12, and 18, a small amount of BM cells were collected from the right tibiae of the mice using a BM aspiration technique. The collected BM cells were stained with a cocktail of mAbs [mouse CD45.1 (Beckman Coulter), CD19, CD33 (Beckman Coulter), and CD34 (BD Bioscience) and human CD45 (BioLegend)], and the human cell repopulation ability was analyzed by FCM (FACSCantoII; BD Bioscience). From weeks 22 to 24 the mice were euthanized, and the multilineage human hematopoietic cell repopulation ability in mouse BM, peripheral blood (PB), spleen, and thymus was analyzed by FCM.
Limiting Dilution Analyses
In order to estimate the frequencies of SRCs in the CB-derived 18Lin 
MPL
+/− cells were transplanted into NOG mice using an IBMI technique, as previously reported [4] [5] [6] [8] [9] [10] . At week 12 the mice were euthanized, and the human CD45 + cell repopulation ability in mouse BM was analyzed by FCM. The frequency of SRC in each fraction was calculated from the dose of transplanted cells, the number of transplanted mice, and the number of human CD45 + cell repopulated mice using an extreme limiting dilution analysis (ELDA) software (http://bioinf. wehi.edu.au/software/elda/) 21 .
Secondary and Tertiary Transplantation
For secondary transplantation, 1/5 of BM cells obtained from pairs of femurs and tibiae of individual primary recipient mice were transplanted into secondary recipient mice, as previously reported 4, 6, 9, 10 . For tertiary transplantations, murine BM cells were obtained from the pairs of femurs and tibiae of engrafted secondary recipient NOG mice at 20 to 23 weeks after transplantation. Tertiary trans plantations were then performed as described for secondary transplantation. Finally, beyond 18 weeks after transplantation, the presence of human CD45 + cells in the BM of tertiary recipients was analyzed by FCM, as described above.
Statistical Analysis
The differences in the mean colony numbers or repopulation levels of human CD45 + cells of each pair were examined by the two-tailed Student's t-test. The differences in the expression levels of lineage markers between each pair of all the means were examined by Tukey's multiple comparison procedure. All statistical analyses were performed using KaleidaGraph software version 3.6 Figure 1 . First, the R1 gate was set on the blast-lymphocyte window (Fig. 1A) . Next, the 7-AAD − 18Lin
− cells were gated as R2 in Figure 1B The CFC capacities of the CB-derived 18Lin − CD34
+/− MPL +/− cells were quite unique. In the presence of 30% FCS and six cytokines (THPO, SCF, IL-3, GM-CSF, G-CSF, and Epo) (Fig. 3A) − MPL +/− cells mainly formed burst forming uniterythroid (BFU-E; 71% and 75%) and CFU-Mix (23% and 10%), whereas they formed few CFU-GM colonies (6% and 14%). Conversely, 18Lin − CD34 + MPL +/− cells formed all types of CFCs, including CFU-GM, BFU-E, and CFU-Mix.
In the presence of 10% PPP and three cytokines (THPO, IL-3, and Epo) (Fig. 3B) (R5-R8) fractions. As shown in (D) and (E), the percentages of MPL + cells in the CD34 + (R5) and CD34 − (R7) fractions ranged from 13.6% to 56.4% (median: 36.9%, n = 9) and 1.4% to 33.1% (median: 10.3%, n = 9), respectively. 7AAD, 7-aminoactinomycin D; FSC, forward scatter; SSC, side scatter. MPL +/− cells were cultured in the semisolid methylcellulose supplemented with 30% fetal calf serum (FCS) in the presence of six cytokines [thrombopoietin (THPO), stem cell factor (SCF), interleukin-3 (IL-3), granulocyte macrophage colony-stimulating factor (GM-CSF), G-CSF, and erythropoietin (Epo)] for 14 days or (B) supplemented with 10% platelet-poor plasma in the presence of three cytokines (THPO, IL-3, and Epo) for 10 days. The types of colonies were identified under inverted microscopy. The data represent the mean ± standard deviation (SD) of quadruple cultures. CFU-GM, colony forming unit-granulocyte/macrophage; BFU-E, erythroid burst-forming unit; CFU-Meg, megakaryocyte; CFU-Mix, erythrocyte-containing mixed; CFU-EM, erythrocyte/megakaryocyte mixed colony. *p < 0.05, **p < 0.01, n.s., not significant. (Fig. 4A) . In contrast, the total number of cells derived (Fig. 4B) . Next, we analyzed the generation of lineage markerpositive cells, including CD33, CD11b, CD14, and CD41 (Fig. 4C-F (Fig. 4C-E) . In contrast, the 18Lin − CD34 − MPL + cells generated significantly higher numbers of CD41 + cells compared with those of the other three cell fractions (Fig. 4F) . These results are consistent with their higher CFU-Meg and CFU-EM colony-forming capacities, as shown in Figure 3 . (4, 5) . Next, we developed a highresolution purification method improving upon our negative selection method, resulting in an incidence of CD34 − SRCs in 18Lin − CD34 − cells of 1/1,000
Limiting Dilution Analysis (LDA) of CB-
. Using this method, we performed an LDA to demonstrate the frequency of the CD34 +/− SRCs in 18Lin Table 2 . The numbers of SRCs transplanted in each recipient mouse were calculated according to the LDA analysis as shown in Figure 5 .
In these experiments, nearly all primary recipient mice that received transplants of CD34 +/− MPL +/− SRCs showed signs of human cell repopulation at 5 weeks after the transplantation (Fig. 6A and C, and Table 2 ). The repopulation level of all engrafted mice that received four classes of SRCs gradually increased and reached the peak levels at 12 to 18 weeks after transplantations. Figure 7 . In addition, the repopulation patterns of the four types of SRCs in all recipient mice are precisely shown in 
MPL +/− SRCs in NOG Mice
We next performed the secondary transplantation to analyze the self-renewing capacities in greater detail. All of the secondary recipient mice (9/9) that received the transplants from the primary recipient mice, which received either 18Lin − CD34 + MPL +/− cells by IBMI, showed signs of human cell repopulation at 20 to 23 weeks after transplantation (Table 2) . Additionally, secondary recipient mice that received 18Lin − CD34 + MPL +/− cells showed comparable median levels of human cell repopulation [0.01% to 28.7% (median: 1.5%) and 0.01% to 61.2% (median: 3.8%), respectively]. The LT repopulation patterns of these engrafted SRCs in NOG mice were nearly comparable (Fig. 6B) . The repopulation levels of all engrafted mice gradually increased and reached peak levels at 12 to 18 weeks after transplantations.
Interestingly, only 1 out of 10 mice that received 18Lin − CD34 − MPL + cells was barely repopulated with human cells. Moreover, the CD45 + cell rates at 12 to 20 weeks after transplantation of this mouse were <1% and decreased to <0.1% at 20 weeks after the transplantation, suggesting that these CD34 − MPL + SRCs were ST-repopulating SRCs (Fig. 6D) . In contrast, almost all of the mice (9/10) that received 18Lin − CD34 − MPL − cells were engrafted with human cells. The repopulation levels of the engrafted mice were 0.01% to 20.5% (median: 0.4%). The repopulation levels of all engrafted mice gradually increased and reached the peak levels at 12 to 18 weeks after transplantations (Fig. 6D) + SRCs could be generated in NOG mice that received a limited number of CB-derived CD34 − SRCs at 20 weeks after transplantation (Fig. 8) . In contrast, CD34 + SRCs could not generate CD34 − SRCs in vitro and in vivo 4,9,17 .
DISCUSSION
It is well documented that THPO is a principal cytokine that regulates megakaryocyte/platelet production, and its signals are transduced through its receptor, MPL [24] [25] [26] [27] . MPL is reported to be expressed not only on megakaryocytes/ platelets but also on HSPCs [24] [25] [26] [27] . As expected, THPO and MPL knockout (KO) mice showed a significant reduction in the numbers of megakaryocytes and circulating platelets as well as HSCs 2, [28] [29] [30] . It was also previously reported that THPO and MPL KO mice showed increased numbers of fetal liver HSCs, but selective and progressive postnatal reduction of LT-HSCs in THPO KO mice 2 . These results demonstrated that the THPO/MPL signaling is not required for fetal HSC expansion, but adult quiescent HSCs are highly THPO/MPL dependent 2 . Conversely, the study and understanding of the function of the THPO/ MPL signaling pathway in human primitive HSCs are far behind that of murine studies. The above-mentioned murine studies have suggested that the functional roles of THPO/MPL signaling in human BM (reflecting adult hematopoiesis) and CB (reflecting fetal hematopoiesis) may be different.
In this study, we purified human CB-derived 18Lin (Fig. 4) . Interestingly, 18Lin − CD34 − MPL + cells generated significantly higher numbers of CD41 + cells compared with those of the other three populations. These results suggested that the THPO/MPL signaling plays a role in the megakaryocytic lineage commitment of CB-derived HSPCs.
Finally, we analyzed the expression patterns of CD34 and MPL on primitive human CB-derived HSCs using 8-90.3 (25.4) 13.8-73.5 (44.0) 15.8-55.9 (37.8) 8.3-25.9 (18. 11, [34] [35] [36] [37] , and life span 3, 6, 8, [38] [39] [40] . Recently, Ema et al. proposed Figure 9 . In our model, we use the following definition: ST-HSCs only support human cell repopulation in primary recipient mice; IT-HSCs support human cell repopulation in primary and secondary recipient mice; and LT-HSCs support human cell repopulation in primary, secondary, and tertiary recipient mice. Previously, Guenechea et Figure 9 . In conclusion, the present study demonstrated for the first time that the expression pattern of CD34 antigen and MPL receptor in the primitive human CB-derived HSCs strongly correlated with the serial transplantation analyses and resulted in the categorization of primitive human HSCs into ST-, IT-, and LT-repopulating HSCs, as shown in Figure 9 . In the SRC assay system using NOG mice, the human THPO/MPL signaling pathway does not work, at least during the early phase of repopulation after transplantation, due to a lack of human active THPO in NOG mice 44 . As previously reported 44 , hematopoiesis in human THPO knockin RAG2 
CD49f
+ cells transplanted directly into the mouse femur could repopulate human hematopoiesis in NOD/ShiLtSz-scid/IL2Rgnull (NSG) mice at 20 weeks after the transplantation 41 . These results clearly indicated that murine BM niche cells and/or some unidentified niche factors could support the homing, proliferation, and even self-renewal of human HSCs at the single-cell level. Therefore, unidentified factors/signals other than THPO/ MPL may play a pivotal role in maintaining the primitive human HSCs in the BM niche of NOG/NSG mice across the species barrier. Overall, these findings suggested that the functional significance of the MPL expression in the human primitive HSC compartment differs from that in the murine primitive HSC compartment. 
